4//SEC Filing
Belldegrun Arie 4
Accession 0001737287-25-000005
CIK 0001737287other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 8:11 PM ET
Size
321.0 KB
Accession
0001737287-25-000005
Insider Transaction Report
Form 4
Belldegrun Arie
Director
Transactions
- Award
Stock Option (Right to buy)
2025-01-24+1,307,927→ 1,307,927 totalExercise: $1.94Exp: 2035-01-24→ Common Stock (1,307,927 underlying) - Award
Common Stock
2025-01-24+369,957→ 2,236,816 total
Holdings
- 1,798,163(indirect: See footnote)
Common Stock
- 539,867(indirect: See footnote)
Common Stock
- 1,724,137(indirect: See footnote)
Common Stock
- 4,710,120(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]The securities are held in the name of Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary
- [F2]The securities are held by Vida Ventures LLC (Vida), of which VV Manager LLC is the manager. There porting person is a Senior Managing Director of VV Manager LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- [F3]The securities are held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. Vida Ventures GP III, LLC is the manager of Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person is a Senior Managing Director of Vida Ventures GP III, LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- [F4]The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun.
- [F5]25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001296549
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 8:11 PM ET
- Size
- 321.0 KB